Blood Plasma Market Analysis By Top Industry Players, Trends And Forecast Upto 2030

Plasma is the fluid part of the blood. Plasma is the flexible part and makes around 55% of the blood. Plasma is the composite blend of in excess of 700 proteins and different substances which are fundamental for the proficient working of the human body. Plasma helps in controlling body temperature and pulse. It fills in as a medium for trade of proteins, supplements and hormones to the diverse parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma.

Browse Full Report:

The Blood Plasma Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Blood Plasma Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covers Immunoglobulin, Albumin, Protease Inhibitors, Coagulation factor concentrates and others. Based on application it is classified as Hospitals and clinics, Research Laboratories and Academic Institutions.

The Blood Plasma Market is expected to exceed more than US$ 44.0 Billion by 2024 at a CAGR of 9.3% in the given forecast period.

The major driving factors of Blood Plasma Market are as follows:

Government and private organization support blood donation camps and programs to meet the rising demand of plasma Rise in prevalence of bleeding disorders Increasing kidney disorder that requires blood plasma product as a therapeutic

The major restraining factors of Blood Plasma Market are as follows:

Stringent regulatory standards on the import and export of plasma product High complexity and cost associated with the collection of blood plasma Dearth of skilled and trained professionals for fractionation procedure

The major opportunities of Blood Plasma Market are as follows:

Identification of new proteins in blood plasma to be used as therapeutic products are under clinical investigation Exploring novel therapeutic application of the known blood plasma product to be used for other diseases

The Blood Plasma Market has been segmented as below:

The Blood Plasma Marketis segmented on the lines ofProduct, Application and Regional Analysis.

By Productthis market is segmented on the basis ofImmunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates and Others. By Applicationthis market is segmented on the basis ofHospitals and Clinics, Research Laboratories and Academic Institutions. By Regional Analysisthis market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Blood Plasma Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Blood Plasma Market

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report scope:

The scope of the report includes a detailed study of Blood Plasma Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Reasons to Buy this Report:

Obtain the most up to date information available on all Blood Plasma Market. Identify growth segments and opportunities in the industry. Facilitate decision making on the basis of strong historic and forecast of Blood Plasma Market. Assess your competitor’s refining portfolio and its evolution.

Request Sample Report from here:

Table of Contents:

Introduction Research Methodology Report Summary Market Overview

4.1    Introduction

4.2    Drivers

4.3    Restrains

4.4    Industry Trends

4.5    Porter’s Five Forces Analysis

Blood Plasma Market Analysis, By Product Blood Plasma Market Analysis, By Application Blood Plasma Market Analysis, By Region Competitive Overview Company Profiles

9.1    Baxter International

9.2    CSL

9.3    Grifols

9.4    Octapharma

9.5    ADMA Biologics

9.6    Cerus Corp

9.7    Sanquin

9.8    Shanghai Raas

9.9    TCS Biosciences

Other Related Market News :


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States